Literature DB >> 16051285

Multidrug resistance reversal agent from Jatropha elliptica.

Béatrice Marquez1, Luc Neuville, Nicole J Moreau, Jean-Pierre Genet, Aldenir Feitosa dos Santos, Maria Cristina Caño de Andrade, Antônio Euzébio Goulart Sant'Ana.   

Abstract

As part of an ongoing project to identify plant natural products as resistance-modifying agents, bioassay-guided fractionation of an extract of Jatropha elliptica (Pohl) Muell Arg. led to the isolation of a penta-substituted pyridine, namely 2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid diethyl ester (8). The structure was established by spectroscopic methods. This known compound was assayed for in vitro antibacterial and resistance-modifying activities against strains of Staphylococcus aureus possessing the MsrA and NorA resistance efflux mechanisms. Antibiotic efflux studies indicated that (8) acts as an inhibitor of the NorA efflux pump and restores the level of intracellular drug concentration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051285     DOI: 10.1016/j.phytochem.2005.06.008

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  13 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 2.  A review on pharmacological significance of genus Jatropha (Euphorbiaceae).

Authors:  Surendra Kr Sharma; Harneet Singh
Journal:  Chin J Integr Med       Date:  2012-10-20       Impact factor: 1.978

3.  The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus.

Authors:  A de Breij; T G Karnaoukh; J Schrumpf; P S Hiemstra; P H Nibbering; J T van Dissel; P C de Visser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-15       Impact factor: 3.267

Review 4.  Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.

Authors:  Meenal Chawla; Jyoti Verma; Rashi Gupta; Bhabatosh Das
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

5.  Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus.

Authors:  Joseph I Ambrus; Michael J Kelso; John B Bremner; Anthony R Ball; Gabriele Casadei; Kim Lewis
Journal:  Bioorg Med Chem Lett       Date:  2008-07-02       Impact factor: 2.823

6.  Effect of ethanolic extract of Ecballium elaterium against Staphylococcus aureus and Candida albicans.

Authors:  Ghaleb Adwan; Yousef Salameh; Kamel Adwan
Journal:  Asian Pac J Trop Biomed       Date:  2011-12

7.  A penta-substituted pyridine alkaloid from the rhizome of Jatropha elliptica (Pohl) Muell. Arg. is active against Schistosoma mansoni and Biomphalaria glabrata.

Authors:  Aldenir Feitosa dos Santos; Saskya Araújo Fonseca; Fernanda Andrade César; Mônica Camelo Pessoa de Azevedo Albuquerque; José Valfrido Santana; Antônio Euzébio Goulart Santana
Journal:  Parasitol Res       Date:  2014-02-06       Impact factor: 2.289

8.  The In Vitro Antimicrobial Effects of Lavandula angustifolia Essential Oil in Combination with Conventional Antimicrobial Agents.

Authors:  Stephanie de Rapper; Alvaro Viljoen; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-06       Impact factor: 2.629

9.  Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.

Authors:  Nan Zhang; Yuzhi Wu; Zilong Huang; Chuanzhen Zhang; Longfei Zhang; Qinren Cai; Xiangguang Shen; Hongxia Jiang; Huanzhong Ding
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

Review 10.  New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.

Authors:  Gabriella Spengler; Annamária Kincses; Márió Gajdács; Leonard Amaral
Journal:  Molecules       Date:  2017-03-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.